Welcome! The Alzheimer's Disease Research Center (ADRC) at Mayo Clinic promotes research and education about healthy brain aging, mild cognitive impairment, Alzheimer's disease, and other related dementia disorders. For patients and families affected by Alzheimer's disease or a related dementia, the ADRC at Mayo Clinic offers education and support programs, as well as opportunities to participate in clinical trials and research discoveries.

This website is dedicated primarily to the community outreach activities of the ADRC at Mayo Clinic in Jacksonville, FL. To view the main Mayo Clinic ADRC website, click here.

Use the menu above or the tiles below to learn more and get involved in our community outreach efforts.

MAYO CLINIC FLORIDA ADRC NEWS


Pressing Toward the Mark: A Faith-Based Approach to Dementia Education

Dr. Maisha Robinson

August 26, 2020

Dr. Maisha Robinson of the Mayo Clinic Alzheimer’s Disease Center was awarded a grant from the Community Foundation of Northeast Florida to forge partnerships with local Black Churches and the Alzheimer’s Association to help provide resources in their approach to congregation members who are having memory issues or other signs of Alzheimer’s Disease and dementia.


Mayo Clinic ADRC investigators study form of Alzheimer's disease that strikes younger adults.

June 17, 2020

Mayo Clinic researchers have defined a form of Alzheimer’s disease that can strike younger people as early as their 40s, presents with symptoms that are different from typical Alzheimer's disease, and affects a different part of the brain than is typically seen in Alzheimer’s disease.

In a paper published in the journal Brain Communications, the ADRC researchers report a series of 55 patients with this form of Alzheimer's disease. The average age of symptom onset was approximately 54 years old, whereas typical Alzheimer's is most likely to appear after age 65. In these patients with younger onset Alzheimer's disease, the progressive dementia syndrome more prominently affected the ability to multitask, organize and plan, whereas the memory deficits seen in typical Alzheimer’s disease were not as significant. In fact, many patients showed no dysfunction or cell loss in the memory center of the brain. This pattern of Alzheimer's disease has been observed before, but the new study helps characterize and understand it better.


A Message to the Community from the Mayo Clinic Florida Alzheimer's Disease Research Center Outreach Team

June 8, 2020

We recognize the long-standing social, economic and political inequalities that underlie current nationwide demonstrations for social justice. We are committed to maintaining and strengthening relationships with our community partners to address disparities in all forms and to eliminate the systemic racism and discrimination that perpetuate these social ills.

We understand that these are unprecedented times but our priority will always be the health and well-being of our community members. We strongly believe that change is needed and we strive to be a positive force for change in the communities we serve.


Statement from Gianrico Farrugia, M.D., President & CEO, Mayo Clinic and Jeff Bolton, Chief Administrative Officer, Mayo Clinic

May 27, 2020

We were deeply saddened and troubled to learn the tragic news of George Floyd’s death in Minneapolis, so close to home to many of us. Mr. Floyd died on Monday after being held down by a Minneapolis police officer.

This is just one of several recent incidents drawing national attention that show that we as a society still have a long way to go in stamping out violence and hate, negative biases and stereotypes.

Mayo Clinic stands united in rejecting all forms of discrimination against our staff, our patients and people in our communities. These incidents are deeply troubling, and combined with daily news about COVID-19, they are even more stressful.

We invite everyone to renew your commitment to supporting our colleagues. Be there for each other, help one another, be a force for good and hope for one another, inside and outside of Mayo Clinic.


Mayo Clinic Florida Resumes Alzheimer's Disease Research Visits & Community Outreach Events

June 1, 2020

The Mayo Clinic Alzheimer’s Disease Center has re-opened and will gradually resume research visits and community outreach activities in the coming weeks. We look forward to resuming our important work of discovering and developing effective therapies in the fight against Alzheimer's disease and AD-related dementia.

Mayo Clinic has taken several extra precautions to safely resume in-person visits, including enhanced cleaning, robust screening, new safety guidelines and strategies to minimize the risk of the COVID-19 virus on our campus.

If you are in a research study, you may receive a call from a study coordinator to schedule an appointment. Some visits may be in-person but for other visits we may be able to offer a virtual visit online. Please feel free to ask your study coordinator about these options. If you have questions, please call us at 904-953-6523.

Similarly, we will be continuing our community partnerships in education, skill-building, and caregiver support. Although some of the larger community events we had planned for this year will need to be scaled back or postponed, we soon plan to move forward with activities such as our Memory Cafe and Community Support groups. Please know that we will do everything possible to ensure community health, wellness, and safety as our top priority, and that we will continue to offer virtual online activities for those unable to join us in person.

Please visit our event calendar for updated information about virtual and in-person events, dates, locations, and links.

Thank you! We hope that you and your loved ones remain safe and healthy.


COVID-19 UPDATE: Mayo ADRC Research Visits & Community Outreach Events Postponed

May 4, 2020 (updated from March 16, 2020)

In response to the COVID-19 outbreak, the Mayo Clinic Alzheimer’s Disease Research Center executive team has suspended all in-person research visits and outreach activities through May 31, 2020. This includes visits to Mayo Clinic for study exams, brain imaging, blood draws, and lumbar puncture procedures. It also includes all in-person educational and support programs and events through at least May 31, 2020.  If you are a research participant who also receives medical care at Mayo Clinic, those appointments will be managed by your healthcare provider on an individual basis. 

We will continue to monitor the situation and will provide updates on our research visits and outreach events as the COVID-19 situation evolves. We would like to thank you all for your dedication to dementia awareness and education, and for your support and commitment to dementia research.

If you are a Mayo Clinic ADRC study participant and have questions about your study visit, please call 904-953-6523.


Dr. Maisha Robinson awarded Florida Department of Health Ed and Ethel Moore Alzheimer's Disease Research Program Grant

January 13, 2020

Dr. Maisha Robinson

Congratulations to Mayo Clinic ADRC investigator, Dr. Maisha Robinson, for being one of 4 Mayo Clinic recipients of a Florida Moore grant. Her project: Between Here and There: Addressing End-of-Life Disparities Among African Americans with MCI and Dementia Through Community-Based Training in Advance Care Planning seeks to empower African American communities to ensure that the end-of-life wishes and preferences of community members with memory loss and dementia are made known, documented, and respected. Gov. Ron DeSantis announced the awards at a press conference on January 13.

The Ed & Ethel Moore grant program funds research seeking to improve the health of Floridians through better prevention, diagnosis, and treatment for Alzheimer’s disease and AD-related dementia. Congratulations are also in order for the three other Mayo ADRC investigators awarded Moore grants:

  • Dr Pamela McLean, Modeling Lewy body dementias: Towards a better understanding of amyloid-beta and alpha-synuclein in ADRDs.
  • Dr. Rickey Carter, Racial and Ethnic Differences in Gene Expression Data.
  • Dr. Pritam Das, Detection of vascular and inflammatory plasma biomarkers in patients diagnosed with obstructive sleep apnea and cerebral small vessel disease.

National Institutes of Health Receive Boost in Alzheimer’s Disease Funding

December 20, 2019

The US Senate has approved a $350 million increase in funding for the National Institutes of Health (NIH) to advance research on Alzheimer’s disease (AD) and AD-related dementia. This raises the total NIH budget for AD research to $2.8 billion for fiscal year 2020, recognizing the widespread public health crisis presented by this disease.
  
Over the last five years, advances in research have led to many discoveries, including new genes and pathways linked to the disease. The increased funding will help keep momentum going towards the discovery of new and effective treatments.

AD cannot currently be cured and is considered the most expensive disease in the country, costing taxpayers $290 billion in 2019. More than 5 million Americans are currently living with the disease and an estimated 16 million more are providing unpaid care to loved ones with dementia. As noted by the Alzheimer’s Association, "we owe it to these individuals and the millions more who will be impacted in the coming years to leave no stone unturned so we can advance treatments and find a cure for this devastating disease."


DR. FLOYD WILLS HONORED AS "COMMUNITY HEALTH HERO"

October 18, 2019

Dr. Floyd Wills, Family Medicine physician and investigator in the Mayo Clinic Alzheimer's Disease Research Center, has been named a recipient of the inaugural "Community Health Heroes" award from Agape Family Health, a local non-profit organization whose mission is to make comprehensive healthcare services available to the entire Jacksonville community, regardless of race, national origin, gender, age or socioeconomic status.

Dr. Willis is recognized for his research in Alzheimer’s disease among African-Americans, as well as for his current partnership with Edward Waters College to examine the potential role of students from minority-serving institutions in providing health education to the surrounding community.